USARx offers multiple ways to purchase this medication. Choose the Best option for you!
Commonly reported side effects of pentoxifylline include: dizziness and nausea. Other side effects include: dyspepsia and vomiting. See below for a comprehensive list of adverse effects.
Applies to pentoxifylline: oral tablet extended release
Along with its needed effects, pentoxifylline may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur while taking pentoxifylline:
Signs and symptoms of overdose (in the order in which they may occur)
Some side effects of pentoxifylline may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to pentoxifylline: compounding powder, oral tablet extended release
Pentoxifylline has been generally well tolerated. While typically minor, side effects have necessitated discontinuation of the drug in approximately 3% of treated patients. Tolerance to mild side effects generally has developed with continued use.
Gastrointestinal side effects have been the most common side effects associated with pentoxifylline therapy and have included dyspepsia, nausea, vomiting, and belching, which occurred in 1% to 3% of patients. Some smaller studies have reported gastrointestinal disturbance in up to 33% of patients treated with pentoxifylline.
Nervous system side effects have occurred in 1% to 2% of treated patients and have included headache, dizziness, insomnia, and tremor. Some smaller studies have reported nervous system adverse effects in up to 17% of treated patients. In addition, rare cases of visual and auditory hallucinations have been reported. Aseptic meningitis has been reported in postmarketing experiences.
Cardiovascular side effects have included reports of palpitations, flushing, and angina. These reports have usually been associated with higher doses of an immediate release capsule which is not available in the United States.
Hematologic side effects have included anecdotal reports of pancytopenia and fatal aplastic anemia.
Hepatic side effects have included postmarketing reports of cholestasis.
Hypersensitivity side effects have included postmarketing reports of anaphylactic reaction, anaphylactoid reaction, and anaphylactic shock.
June 25, 2020
June 23, 2020
June 22, 2020
June 18, 2020
June 17, 2020
June 4, 2020